{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-000010","form_type":"8-K/A","ticker":"HBIO","cik":"0001123494","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2023-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.921392+00:00","generated_at":"2026-06-20T20:44:00.131128+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Harvard Bioscience sets compensation for Interim CFO Cote: $270K salary, bonus, $75K RSU","bullets":["Annual base salary of $270,000 as Interim CFO and Treasurer, effective January 1, 2023.","Eligible for cash bonus of 25% of 2023 base salary, paid in quarterly installments.","One-time equity award of RSUs with $75,000 grant date value, vesting December 29, 2023.","Compensation package is in addition to prior VP Finance terms from April 2022 offer letter."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-000010","json":"https://secwatch.observer/filing/0001171843-23-000010.json","markdown":"https://secwatch.observer/filing/0001171843-23-000010.md","text":"https://secwatch.observer/filing/0001171843-23-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184323000010/0001171843-23-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184323000010/f8ka_010323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T20:44:00.131128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}